Follow
Thomas E Speltz
Thomas E Speltz
Evozyne
Verified email at evozyne.com
Title
Cited by
Cited by
Year
Stapled peptides with γ‐methylated hydrocarbon chains for the estrogen receptor/coactivator interaction
TE Speltz, SW Fanning, CG Mayne, C Fowler, E Tajkhorshid, GL Greene, ...
Angewandte Chemie 128 (13), 4324-4327, 2016
912016
Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway
BG Richardson, AD Jain, TE Speltz, TW Moore
Bioorganic & medicinal chemistry letters 25 (11), 2261-2268, 2015
742015
A research-based undergraduate organic laboratory project: investigation of a one-pot, multicomponent, environmentally friendly Prins–Friedel–Crafts-type reaction
MR Dintzner, JJ Maresh, CR Kinzie, AF Arena, T Speltz
Journal of Chemical Education 89 (2), 265-267, 2012
372012
Versatile peptide macrocyclization with Diels–Alder cycloadditions
JE Montgomery, JA Donnelly, SW Fanning, TE Speltz, X Shangguan, ...
Journal of the American Chemical Society 141 (41), 16374-16381, 2019
362019
A “cross-stitched” peptide with improved helicity and proteolytic stability
TE Speltz, CG Mayne, SW Fanning, Z Siddiqui, E Tajkhorshid, GL Greene, ...
Organic & biomolecular chemistry 16 (20), 3702-3706, 2018
342018
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction
TE Speltz, JM Danes, JD Stender, J Frasor, TW Moore
ACS chemical biology 13 (3), 676-684, 2018
322018
Recent structural advances in constrained helical peptides
KJ Skowron, TE Speltz, TW Moore
Medicinal research reviews 39 (2), 749-770, 2019
292019
Steroid receptor/coactivator binding inhibitors: An update
KJ Skowron, K Booker, C Cheng, S Creed, BP David, PR Lazzara, A Lian, ...
Molecular and cellular endocrinology 493, 110471, 2019
252019
Chemoselective Zinc/HCl reduction of halogenated β-nitrostyrenes: synthesis of halogenated dopamine analogues
JJ Maresh, AA Ralko, TE Speltz, JL Burke, CM Murphy, Z Gaskell, ...
Synlett 25 (20), 2891-2894, 2014
202014
Targeting MYC with modular synthetic transcriptional repressors derived from bHLH DNA-binding domains
TE Speltz, Z Qiao, CS Swenson, X Shangguan, JS Coukos, CW Lee, ...
Nature biotechnology 41 (4), 541-551, 2023
132023
Using tumor explants for imaging mass spectrometry visualization of unlabeled peptides and small molecules
BP David, O Dubrovskyi, TE Speltz, JJ Wolff, J Frasor, LM Sanchez, ...
ACS medicinal chemistry letters 9 (7), 768-772, 2018
92018
Novel Copolymers of Styrene. 4. Halophenoxy Ring-Substituted 2-Cyano-3-phenyl-2-propenamides
GB Kharas, NJ Kuffel, T Speltz, E Bittar, D Canby, AE Grecco, AD Jacks, ...
Journal of Macromolecular Science, Part A 52 (1), 10-14, 2015
42015
Protein targeting with SAF (er) electrophiles
TE Speltz, RE Moellering
Nature Chemistry 12 (10), 885-887, 2020
22020
Synthetic dna binding domains and uses thereof
RE Moellering, TE Speltz, S Shangguan
US Patent App. 18/038,633, 2024
2024
Stapled peptide inhibitors of mutant estrogen receptor/coactivator interactions
TE Speltz, JM Danes, SW Fanning, CG Mayne, E Tajkhorshid, GL Greene, ...
Cancer Research 78 (13_Supplement), 1810-1810, 2018
2018
Optimization of stapled peptide inhibitors of the estrogen receptor/coactivator interaction
T Moore, T Speltz, C Mayne, J Danes, S Fanning, B David, G Greene, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018
2018
Engineering natural sidechains from leucine and isoleucine into" stapling" amino acids to inhibit the estrogen receptor/coactivator interaction
T Moore, T Speltz
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–17